風邪薬とインフルエンザ薬の世界市場レポート 2025年

風邪薬とインフルエンザ薬の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.4%で285億4,000万米ドルに成長します。予測期間中に予測される成長は、季節性インフルエンザの流行の増加、呼吸器感染症の原因となる大気汚染の増加、抗生物質耐性の症例の増加、免疫力を高めるサプリメントの人気の高まり、セルフメディケーションに対する意識の高まりなどに起因しています。この時期の主な動向としては、個別化医療、配合剤や自然療法の開発、点鼻薬や吸入器の主な発展、戦略的提携、即効性のある製剤の開発などが挙げられます。

ウイルス感染症の頻度の増加が、今後の風邪薬とインフルエンザ薬市場の拡大を牽引すると予想されます。ウイルス感染症は、ウイルスが宿主細胞内に侵入・増殖することで引き起こされ、さまざまな症状を引き起こします。ウイルス感染症の増加は、主に旅行者の増加によるもので、旅行者が地域や国を越えてウイルスを拡散させることで、新たな集団にウイルスが到達し、アウトブレイクを引き起こします。風邪薬とインフルエンザ薬は、発熱、鼻づまり、疼痛などの症状を緩和し、免疫系がウイルスと闘う間の緩和を提供することで、ウイルス感染症の管理に役立ちます。例えば、2025年1月、米国を拠点とし、南北アメリカにおける国際保健協力に重点を置く機関である汎米保健機構（Pan American Health Organization）は、2025年1月上旬の世界のインフルエンザ陽性率は22.05％であり、季節的に20％増加したと報告しています。このように、ウイルス感染症の罹患率の上昇が風邪薬とインフルエンザ薬市場の成長に寄与しています。

風邪薬とインフルエンザ薬市場の主要企業は、人工添加物を含まない、より安全で自然な代替品を子供たちに提供するため、クリーンな市販薬（OTC薬）などの革新的製品の開発に注力しています。一般用医薬品は処方箋なしで購入できる医薬品で、頭痛や風邪、軽い痛みなど日常的な症状の治療によく使われます。例えば、2023年9月、米国のクリーンメディスン企業であるジェネクサ社（Genexa Inc.）は、「キッズ・マルチシンプトム・コールド＆インフルエンザ」や「キッズ・昼用＋夜用咳止めバリューパック」など、クリーンなOTC小児用医薬品を発売しました。これらの製品は、人工色素、甘味料、保存料を使用せず、効果的な有効成分を配合しており、子どもの風邪やインフルエンザの症状に、より安全で自然な選択肢を提供するとともに、発熱、のどの痛み、鼻づまりなどの症状を緩和します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の風邪薬とインフルエンザ薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の風邪薬とインフルエンザ薬市場：成長率分析
• 世界の風邪薬とインフルエンザ薬市場の実績：規模と成長, 2019-2024
• 世界の風邪薬とインフルエンザ薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界の風邪薬とインフルエンザ薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の風邪薬とインフルエンザ薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ヒスタミン薬
• 去痰薬
• 気管支拡張薬
• 鼻づまり解消薬
• その他のタイプ
• 世界の風邪薬とインフルエンザ薬市場：剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• カプセル
• シロップ
• トローチ
• その他の剤形
• 世界の風邪薬とインフルエンザ薬市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 先天性下垂体性小人症
• 後天性下垂体性小人症
• 遺伝性症候群
• その他のホルモン障害
• 世界の風邪薬とインフルエンザ薬市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児患者
• 思春期の患者
• 成人患者
• 高齢患者
• 世界の風邪薬とインフルエンザ薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 在宅ケア設定
• 製薬会社および調査機関
• 世界の風邪薬とインフルエンザ薬市場、抗ヒスタミン薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 第一世代抗ヒスタミン薬
• 第二世代抗ヒスタミン薬
• 複合抗ヒスタミン薬
• 世界の風邪薬とインフルエンザ薬市場、去痰薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• グアイフェネシン系去痰薬
• ハーブ去痰薬
• 複合去痰薬
• 世界の風邪薬とインフルエンザ薬市場、気管支拡張薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ベータ作動薬
• 抗コリン薬
• 複合気管支拡張薬
• 世界の風邪薬とインフルエンザ薬市場、充血除去薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口充血除去薬
• 鼻づまり解消スプレー
• 複合充血除去薬
• 世界の風邪薬とインフルエンザ薬市場、その他のタイプ、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 鎮痛剤
• 咳止め薬
• 解熱剤
• 鼻スプレー
• 免疫強化剤

第7章 地域別・国別分析

• 世界の風邪薬とインフルエンザ薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の風邪薬とインフルエンザ薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 風邪薬とインフルエンザ薬市場：競合情勢
• 風邪薬とインフルエンザ薬市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Reckitt Benckiser Group plc
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals plc
• Lupin Limited
• Pyxus International Inc.
• Glenmark Pharmaceuticals Ltd.
• The Kroger Co.
• Saphnix Life Sciences
• Arlak Biotech Pvt Ltd
• AdvaCare Pharma
• Sterling Pharmaceuticals
• Biophar Lifesciences Pvt Ltd
• Nutra Respiro

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 風邪薬とインフルエンザ薬市場2029：新たな機会を提供する国
• 風邪薬とインフルエンザ薬市場2029：新たな機会を提供するセグメント
• 風邪薬とインフルエンザ薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cold and flu drugs are pharmaceutical medications designed to alleviate symptoms associated with the common cold and influenza (flu). These medications help relieve symptoms such as fever, cough, congestion, sore throat, body aches, and others, improving comfort and supporting recovery.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of cold and flu drugs include antihistamines, expectorants, bronchodilators, decongestants, and other variants. Antihistamines are drugs that block histamine receptors to relieve allergy and cold symptoms such as sneezing, itching, and nasal congestion. These drugs come in various dosage forms, including tablets, capsules, syrups, lozenges, and others. They are used for a range of conditions, including congenital pituitary dwarfism, acquired pituitary dwarfism, genetic syndromes, and other hormonal disorders. These medications are administered to patients across various age groups, including pediatric, adolescent, adult, and geriatric populations. They are used by several end-users, such as hospitals, specialized clinics, homecare settings, pharmaceutical companies, and research institutions.

The cold and flu drugs market research report is one of a series of new reports from The Business Research Company that provides cold and flu drugs market statistics, including the cold and flu drugs global market size, regional shares, competitors with the cold and flu drugs market share, detailed cold and flu drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the cold and flu drugs. This cold and flu drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cold and flu drugs market size has grown rapidly in recent years. It will grow from $17.35 billion in 2024 to $19.19 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth observed during the historic period can be attributed to the increasing aging population, the growing popularity of over-the-counter (OTC) medications, expanding urbanization, rising demand for herbal and natural remedies, and higher healthcare expenditure.

The cold and flu drugs market size is expected to see rapid growth in the next few years. It will grow to $28.54 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth projected during the forecast period can be attributed to the increasing prevalence of seasonal influenza, the rise in air pollution contributing to respiratory infections, the growing cases of antibiotic resistance, the rising popularity of immunity-boosting supplements, and heightened awareness about self-medication. Key trends during this period include personalized medicine, the development of combination products and natural remedies, advancements in nasal sprays and inhalers, strategic collaborations, and the creation of fast-acting formulations.

The growing frequency of viral infections is expected to drive the expansion of the cold and flu drugs market in the future. A viral infection is caused when viruses invade and multiply within host cells, leading to a variety of symptoms. The rise in viral infections is primarily due to increased travel, which facilitates the spread of viruses across regions and countries, enabling them to reach new populations and cause outbreaks. Cold and flu drugs help manage viral infections by alleviating symptoms such as fever, congestion, and pain, offering relief while the immune system works to fight the virus. For example, in January 2025, the Pan American Health Organization, a U.S.-based agency focused on international health cooperation in the Americas, reported a 22.05% influenza positivity rate globally in early January 2025, marking a 20% seasonal increase. Thus, the rising incidence of viral infections is contributing to the growth of the cold and flu drugs market.

Leading companies in the cold and flu drugs market are focusing on developing innovative products, such as clean over-the-counter (OTC) medicines, to provide safer, natural alternatives for children, free from artificial additives. Over-the-counter (OTC) medicines are drugs that can be purchased without a prescription, commonly used for treating everyday conditions such as headaches, colds, and minor pain. For instance, in September 2023, Genexa Inc., a U.S.-based clean medicine company, launched clean OTC children's medicines, including the Kids' Multi-Symptom Cold & Flu and Kids' Daytime + Nighttime Cough Relief Value Pack. These products feature effective active ingredients without artificial dyes, sweeteners, or preservatives, providing a safer and more natural alternative for treating children's cold and flu symptoms, while offering relief for issues such as fever, sore throat, and congestion.

In February 2023, Vir Biotechnology Inc., a U.S.-based biotechnology firm, formed a partnership with GlaxoSmithKline to develop new therapies for influenza. This collaboration aims to ensure continued access to sotrovimab for authorized patients, while also jointly advancing the development of new treatments for influenza and other respiratory illnesses. Additionally, Vir Biotechnology is pursuing next-generation solutions for COVID-19 and potential future coronavirus outbreaks. GlaxoSmithKline is a U.K.-based biopharma company specializing in over-the-counter (OTC) medications for cold and flu symptoms.

Major players in the cold and flu drugs market are Johnson & Johnson, Roche Holding AG, Bayer AG, Sanofi S.A., Viatris Inc., Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Pyxus International Inc., Glenmark Pharmaceuticals Ltd., The Kroger Co., Saphnix Life Sciences, Arlak Biotech Pvt Ltd, AdvaCare Pharma, Sterling Pharmaceuticals, Biophar Lifesciences Pvt Ltd, Nutra Respiro.

North America was the largest region in the cold and flu drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cold and flu drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cold and flu drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cold and flu drugs market consist of sales of cough suppressants, nasal sprays, antiviral medications, sore throat sprays, and fever reducers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cold And Flu Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cold and flu drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cold and flu drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cold and flu drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Antihistamines; Expectorants; Bronchodilators; Decongestants; Other Types
• 2) By Dosage Form: Tablets; Capsules; Syrups; Lozenges; Other Dosage Forms
• 3) By Indication: Congenital Pituitary Dwarfism; Acquired Pituitary Dwarfism; Genetic Syndromes; Other Hormonal Disorders
• 4) By Age Group: Pediatric Patients; Adolescent Patients; Adult Patients; Geriatric Patients
• 5) By End-User: Hospitals; Specialized Clinics; Homecare Settings; Pharmaceuticals And Research Institutions
• Subsegments:
• 1) By Type: First-Generation Antihistamines; Second-Generation Antihistamines; Combination Antihistamines
• 2) By Type: Guaifenesin-Based Expectorants; Herbal Expectorants; Combination Expectorants
• 3) By Type: Beta-Agonists; Anticholinergics; Combination Bronchodilators
• 4) By Type: Oral Decongestants; Nasal Spray Decongestants; Combination Decongestants
• 5) By Type: Pain Relievers; Cough Suppressants; Antipyretics; Nasal Sprays; Immune Boosters
• Companies Mentioned: Johnson & Johnson; Roche Holding AG; Bayer AG; Sanofi S.A.; Viatris Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cold And Flu Drugs Market Characteristics

3. Cold And Flu Drugs Market Trends And Strategies

4. Cold And Flu Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cold And Flu Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cold And Flu Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cold And Flu Drugs Market Growth Rate Analysis
• 5.4. Global Cold And Flu Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cold And Flu Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cold And Flu Drugs Total Addressable Market (TAM)

6. Cold And Flu Drugs Market Segmentation

• 6.1. Global Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Expectorants
• Bronchodilators
• Decongestants
• Other Types
• 6.2. Global Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Syrups
• Lozenges
• Other Dosage Forms
• 6.3. Global Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Congenital Pituitary Dwarfism
• Acquired Pituitary Dwarfism
• Genetic Syndromes
• Other Hormonal Disorders
• 6.4. Global Cold And Flu Drugs Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric Patients
• Adolescent Patients
• Adult Patients
• Geriatric Patients
• 6.5. Global Cold And Flu Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialized Clinics
• Homecare Settings
• Pharmaceuticals And Research Institutions
• 6.6. Global Cold And Flu Drugs Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• First-Generation Antihistamines
• Second-Generation Antihistamines
• Combination Antihistamines
• 6.7. Global Cold And Flu Drugs Market, Sub-Segmentation Of Expectorants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Guaifenesin-Based Expectorants
• Herbal Expectorants
• Combination Expectorants
• 6.8. Global Cold And Flu Drugs Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Beta-Agonists
• Anticholinergics
• Combination Bronchodilators
• 6.9. Global Cold And Flu Drugs Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Decongestants
• Nasal Spray Decongestants
• Combination Decongestants
• 6.10. Global Cold And Flu Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Relievers
• Cough Suppressants
• Antipyretics
• Nasal Sprays
• Immune Bosters

7. Cold And Flu Drugs Market Regional And Country Analysis

• 7.1. Global Cold And Flu Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cold And Flu Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cold And Flu Drugs Market

• 8.1. Asia-Pacific Cold And Flu Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cold And Flu Drugs Market

• 9.1. China Cold And Flu Drugs Market Overview
• 9.2. China Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cold And Flu Drugs Market

• 10.1. India Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cold And Flu Drugs Market

• 11.1. Japan Cold And Flu Drugs Market Overview
• 11.2. Japan Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cold And Flu Drugs Market

• 12.1. Australia Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cold And Flu Drugs Market

• 13.1. Indonesia Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cold And Flu Drugs Market

• 14.1. South Korea Cold And Flu Drugs Market Overview
• 14.2. South Korea Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cold And Flu Drugs Market

• 15.1. Western Europe Cold And Flu Drugs Market Overview
• 15.2. Western Europe Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cold And Flu Drugs Market

• 16.1. UK Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cold And Flu Drugs Market

• 17.1. Germany Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cold And Flu Drugs Market

• 18.1. France Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cold And Flu Drugs Market

• 19.1. Italy Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cold And Flu Drugs Market

• 20.1. Spain Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cold And Flu Drugs Market

• 21.1. Eastern Europe Cold And Flu Drugs Market Overview
• 21.2. Eastern Europe Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cold And Flu Drugs Market

• 22.1. Russia Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cold And Flu Drugs Market

• 23.1. North America Cold And Flu Drugs Market Overview
• 23.2. North America Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cold And Flu Drugs Market

• 24.1. USA Cold And Flu Drugs Market Overview
• 24.2. USA Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cold And Flu Drugs Market

• 25.1. Canada Cold And Flu Drugs Market Overview
• 25.2. Canada Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cold And Flu Drugs Market

• 26.1. South America Cold And Flu Drugs Market Overview
• 26.2. South America Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cold And Flu Drugs Market

• 27.1. Brazil Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cold And Flu Drugs Market

• 28.1. Middle East Cold And Flu Drugs Market Overview
• 28.2. Middle East Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cold And Flu Drugs Market

• 29.1. Africa Cold And Flu Drugs Market Overview
• 29.2. Africa Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cold And Flu Drugs Market Competitive Landscape And Company Profiles

• 30.1. Cold And Flu Drugs Market Competitive Landscape
• 30.2. Cold And Flu Drugs Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cold And Flu Drugs Market Other Major And Innovative Companies

• 31.1. Reckitt Benckiser Group plc
• 31.2. Sun Pharmaceutical Industries Ltd.
• 31.3. Perrigo Company plc
• 31.4. Dr. Reddy's Laboratories Ltd.
• 31.5. Hikma Pharmaceuticals plc
• 31.6. Lupin Limited
• 31.7. Pyxus International Inc.
• 31.8. Glenmark Pharmaceuticals Ltd.
• 31.9. The Kroger Co.
• 31.10. Saphnix Life Sciences
• 31.11. Arlak Biotech Pvt Ltd
• 31.12. AdvaCare Pharma
• 31.13. Sterling Pharmaceuticals
• 31.14. Biophar Lifesciences Pvt Ltd
• 31.15. Nutra Respiro

32. Global Cold And Flu Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cold And Flu Drugs Market

34. Recent Developments In The Cold And Flu Drugs Market

35. Cold And Flu Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Cold And Flu Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cold And Flu Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cold And Flu Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34796_Cold_And_Flu_Drugs_GMR_2025